Morgan Stanley Maintains Prime Medicine(PRME.US) With Hold Rating, Maintains Target Price $5

Moomoo NewsNov 15 08:31 ET · Ratings

Prime Medicine, Inc. (PRME) Gets a Hold From Morgan Stanley

TipRanksNov 15 08:17 ET · Ratings

A Quick Look at Today's Ratings for Prime Medicine(PRME.US), With a Forecast Between $7 to $14

Moomoo NewsNov 14 08:00 ET · Ratings

Is Prime Medicine (NASDAQ:PRME) In A Good Position To Deliver On Growth Plans?

Yahoo FinanceNov 14 07:10 ET

Prime Medicine Reports Q3 2024 Financial Progress

TipRanksNov 13 23:06 ET

Prime Medicine Is Maintained at Buy by Chardan Capital

Dow JonesNov 13 18:56 ET · Ratings